BUTLER JOHN P. (CEO and President) sold 9.4% of their position (341.31K shares) of AKEBIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $474.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/4/2026ACC: 0001591467-26-000002
DirectorOfficer· CEO and President
Since Mar 2026
-166.06K
Net shares
Net seller
$474.4K
Total sold
4
Open market trades
0B · 4S
5
Total transactions
175.25K acquired · 341.31K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−46.66K
Price / share
$1.39
Trade value
$64.86K
% of position
1.3%
2/2/2026
3.46M→3.42M
Common Stock
Direct
Shares
−96.06K
Price / share
$1.39
Trade value
$133.53K
% of position
2.8%
2/2/2026
3.42M→3.32M
Common Stock
Direct
Shares
−114.89K
Price / share
$1.39
Trade value
$159.70K
% of position
3.5%
2/2/2026
3.32M→3.21M
Common Stock
Direct
Shares
+175.25K
Price / share
$1.41
Trade value
$247.10K
% of position
5.5%
2/2/2026
3.21M→3.38M
Common Stock
Direct
Shares
−83.69K
Price / share
$1.39
Trade value
$116.33K
% of position
2.5%
2/2/2026
3.38M→3.30M
Total
Net shares
−166.06K
Net value
-$227.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −46.66K | $1.39 | $64.86K | 1.3% | 3.46M | 3.42M |
| Common Stock Direct | 2/2/2026 | S · Sale | −96.06K | $1.39 | $133.53K | 2.8% | 3.42M | 3.32M |
| Common Stock Direct | 2/2/2026 | S · Sale | −114.89K | $1.39 | $159.70K | 3.5% | 3.32M | 3.21M |
| Common Stock Direct | 2/2/2026 | A · Award | +175.25K | $1.41 | $247.10K | 5.5% | 3.21M | 3.38M |
| Common Stock Direct | 2/2/2026 | S · Sale | −83.69K | $1.39 | $116.33K | 2.5% | 3.38M | 3.30M |
| Total | −166.06K | -$227.31K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned159.93K
Total
159.93K indirect159.93K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 159.93K | Indirect |
| Total | 159.93K | 159.93K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported